Alpha Synuclein Constructs for Neurodegenerative Disease Research
StressMarq has developed unique alpha synuclein constructs to provide invaluable support to researchers engaged in disease model development and the
Read moreStressMarq has developed unique alpha synuclein constructs to provide invaluable support to researchers engaged in disease model development and the
Read moreStressMarq is a pioneer in the development of tau proteins that facilitate the investigation of tau aggregation, a key characteristic
Read moreParkinson’s Disease is characterized by the aggregation of alpha-synuclein, a key pathological feature. In this informative video, the mechanism underlying
Read moreTau is a key protein implicated in neurodegenerative diseases, such as Alzheimer’s and dementia. Tau Pre-formed Fibrils (PFFs) for Modelling
Read moreSonification: What, Why, How and Best Practices A StressMarq Biosciences .pdf White Paper Neurodegenerative Disease Research As populations age, the
Read moreNeuroscience is an interdisciplinary science devoted to the study of the nervous system’s structure and function. A StressMarq Biosciences .pdf
Read moreMcMaster University and the Massachusetts Institute of Technology researchers using artificial intelligence (AI) have discovered a new type of antibiotic
Read moreThe $1 billion acquisition deal is set to advance Ironwood’s vision of becoming the leading gastrointestinal healthcare company. Ironwood Pharmaceuticals,
Read moreKrystal Biotech, Inc., a Pennsylvania-headquartered biotech company specialising in genetic medicines for rare diseases, announced on Friday that the US
Read moreCoya Therapeutics’ investigational low-dose interleukin-2 (IL-2) for subcutaneous administration, COYA 301, has been found to increase Treg function and halt
Read more